Baclofen Toxicity in Children With Acute Kidney Injury: Case Reports and Review of the Literature.

baclofen children dystonia kidney injury rehabilitation spasticity traumatic brain injury

Journal

Child neurology open
ISSN: 2329-048X
Titre abrégé: Child Neurol Open
Pays: United States
ID NLM: 101691975

Informations de publication

Date de publication:
Historique:
received: 09 04 2020
revised: 15 05 2020
accepted: 27 05 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 9 7 2020
Statut: epublish

Résumé

Baclofen is a medication used for tone management in cerebral palsy. Although it acts mainly at the spinal cord level, it can cause central nervous system adverse reactions at higher doses. Baclofen is mainly eliminated by renal excretion and there have been reports on adverse events when used in adults with renal impairment; however, there are no consensus guidelines as to the dose adjustments required due to renal impairment. The authors describe 2 children with acute kidney injury (AKI) and systemic side effects with initiation of oral baclofen, which was started for treatment of dystonia/spasticity in the recovery phase of their kidney injury. Following the initiation of the drug, they both had decreased level of consciousness and respiratory difficulties, which warranted discontinuation of the drug. These cases highlight the need for reduced initial dose, slow titration, and close monitoring when initiating baclofen treatment in children with AKI.

Identifiants

pubmed: 32637443
doi: 10.1177/2329048X20937113
pii: 10.1177_2329048X20937113
pmc: PMC7315666
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2329048X20937113

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Toxicol Clin Toxicol. 1984 Jul;22(1):11-20
pubmed: 6492227
J Child Neurol. 1996 Mar;11(2):77-83
pubmed: 8881981
Am J Kidney Dis. 2018 Feb;71(2):275-280
pubmed: 28899601
Iran J Child Neurol. 2017 Summer;11(3):15-18
pubmed: 28883871
Int J Clin Pharmacol Ther. 2018 Oct;56(10):467-475
pubmed: 29974857
Basic Clin Pharmacol Toxicol. 2015 May;116(5):452-6
pubmed: 25351863
Eur J Clin Pharmacol. 1989;37(2):181-4
pubmed: 2792173
Pediatr Emerg Care. 2001 Apr;17(2):110-2
pubmed: 11334090
J Clin Pharmacol. 2014 May;54(5):584-92
pubmed: 24414993
J Pediatr. 2014 May;164(5):1181-1188.e8
pubmed: 24607242
Vet Hum Toxicol. 1994 Oct;36(5):448-50
pubmed: 7839572
Postgrad Med J. 1972 Oct;48:Suppl 5:9-13
pubmed: 4668367
Ann Agric Environ Med. 2017 Dec 23;24(4):566-569
pubmed: 29284225
Curr Treat Options Neurol. 2005 Nov;7(6):427-39
pubmed: 16221366

Auteurs

Ram A Mishaal (RA)

Sunny Hill Health Centre for Children, Vancouver, British Columbia, Canada.
BC Children's Hospital, Vancouver, British Columbia, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Nancy E Lanphear (NE)

Sunny Hill Health Centre for Children, Vancouver, British Columbia, Canada.
BC Children's Hospital, Vancouver, British Columbia, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Erez Armarnik (E)

Sunny Hill Health Centre for Children, Vancouver, British Columbia, Canada.
BC Children's Hospital, Vancouver, British Columbia, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Esias R van Rensburg (ER)

Sunny Hill Health Centre for Children, Vancouver, British Columbia, Canada.
BC Children's Hospital, Vancouver, British Columbia, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Douglas G Matsell (DG)

BC Children's Hospital, Vancouver, British Columbia, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Classifications MeSH